12 unknown. 12 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 12 |
| Phase 3 | 4 | Unknown 4 |
| Phase 1 | 1 | Unknown 1 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers Topical Pentoxifylline Gel (Vehicle +PTX), Topical Placebo Gel (Vehicle) - Behcet Syndrome, Behcet Disease | Phase 2 | Unknown | Silk Road Therapies, Inc. | 60 | 2024-02-01 | 2023-08-03 |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients reduction or discontinuation of Adalimumab - Uveitis, Adalimumab | Phase 2 | Unknown | Dan Liang | 28 | 2021-01-01 | 2021-12-13 |
| Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis Adalimumab plus Methotrexate - Uveitis | Phase 2 | Unknown | Sun Yat-sen University | 30 | 2020-02-01 | 2021-12-28 |
| Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos - Uveitis | Phase 2 / Phase 3 | Unknown | Fakultas Kedokteran Universitas Indonesia | 20 | 2020-01-21 | 2021-02-03 |
| Tofacitinib for Inflammatory Eye Disease tofacitinib - Uveitis, Scleritis | Phase 2 | Unknown | Washington University School of Medicine | 5 | 2019-04-04 | 2021-02-01 |
| Anti IL-18 (GSK1070806) in Behcet's Disease GSK1070806 - Behcet's Disease | Phase 2 | Unknown | Cambridge University Hospitals NHS Foundation Trust | 12 | 2018-08-01 | 2018-05-11 |
| Conbercept in Choroidal Neovascularization Secondary to Uveitis Conbercept, sham - Choroidal Neovascularization, Uveitis | Phase 2 | Unknown | Chongqing Medical University | 40 | 2016-11-01 | 2016-10-17 |
| Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients Simvastatin, Placebo - Uveitis | Phase 2 / Phase 3 | Unknown | University College, London | 50 | 2015-09-01 | 2017-10-26 |
| Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Tocilizumab - Intermediate Uveitis, Posterior Uveitis | Phase 1 / Phase 2 | Unknown | University of Nebraska | 36 | 2013-03-01 | 2017-04-28 |
| Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Adalimumab - Uveitis | Phase 2 / Phase 3 | Unknown | Heidelberg University | 40 | 2006-08-01 | 2012-12-03 |
| Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis Heparin Surface-Modified Intraocular Lens - Cataract, Uveitis | Phase 2 | Unknown | National Eye Institute (NEI) | 1994-03-01 | 2005-06-24 |
Behcet Syndrome (2) · Cataract (1) · Central Serous Chorioretinopathy (1) · Choroidal Neovascularization (1) · Macular Edema (1) · Pars Planitis (1) · Scleritis (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1)
Eye Diseases (12) · Uveal Diseases (12) · Panuveitis (4) · Cardiovascular Diseases (2) · Choroid Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hereditary Autoinflammatory Diseases (2) · Mouth Diseases (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Stomatognathic Diseases (2)
Adalimumab (2) · 5-(tetradecyloxy)-2-furancarboxylic acid (1) · GSK1070806 (1) · KH902 fusion protein (1) · Methotrexate (1) · Pentoxifylline (1) · Simvastatin (1) · Triamcinolone Acetonide (1) · salicylhydroxamic acid (1) · tocilizumab (1) · tofacitinib (1)
Benha University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Chongqing Medical University (1) · Dan Liang (1) · Fakultas Kedokteran Universitas Indonesia (1) · Heidelberg University (1) · National Eye Institute (NEI) (1) · Silk Road Therapies, Inc. (1) · Sun Yat-sen University (1) · University College, London (1) · University of Nebraska (1) · Washington University School of Medicine (1)
United States (4) · China (2) · United Kingdom (2) · Egypt (1) · Germany (1) · Indonesia (1)
Ahmed A Abdelshafy, MD (1) · Andew J Sulich, MD (1) · Dan Liang, MD (1) · Dan Liang, PhD (1) · Hannes M Lorenz, MD (1) · Lukman Edwar, SpM(K), Dr (1) · Lynn M Hassman, MD PhD (1) · Matthias D Becker, MD (1) · Oren Tomkins-Netzer, MD, PhD (1) · Quan D Nguyen, MD, MSc (1) · Regina Max, MD (1) · Rona M Smith, MD MRCP (1) · Sue Lightman, PhD,FRCOphth (1)
PMID 37172782, PMID 33042579, PMID 38652891
2014 (1)